OGN is currently developing the following drugs: Vehicle Cream, Tapinarof Cream, 1%, Vtama (Tapinarof) Cream, 1%, Atozet 10/40 Mg Or 10/80 Mg, Lipitor 40 Mg Or 80 Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.